Papaverine Hydrochloride for Injection

Pharmacological action: Papaverine hydrochloride has a relaxant effect on visceral and vascular smooth muscles, directly inhibiting abnormal tension and spasm of smooth muscles, especially the spasmodic contraction of smooth muscles.

1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline hydrochloride

This product is white loose mass or powder.

This product is a vasodilator. It is used to treat ischemia caused by spasm of the brain, heart and peripheral blood vessels, and spasm of the kidneys, gallbladder or gastrointestinal tract and other internal organs.

Each vial of this product must be completely dissolved with an appropriate amount of injection water before use. The usual dosage for adults is slow intramuscular injection, 30 mg at a time, 90-120 mg per day. Intravenous injection, 30-120 mg at a time, once every 3 hours, should be injected slowly, not less than 1-2 minutes, to avoid arrhythmia and fatal suffocation. When used for cardiac arrest, the two doses should be separated by 10 minutes. Slow intravenous drip, diluted with 0.9% sodium chloride injection and dripped, 30 mg at a time (calculated as papaverine hydrochloride), 90-120 mg per day, divided into 3-4 doses.

1. Jaundice may occur after medication, manifested as obvious yellowing of the eyes and skin, indicating liver damage. 2. Nausea, vomiting, loss of appetite, constipation, headache, drowsiness and allergic reactions may occur. 3. Redness, swelling or pain of the skin at the injection site may occur. Rapid administration may cause deeper breathing, flushing, accelerated heartbeat, hypotension and dizziness. 4. Overdose may cause blurred vision, diplopia, drowsiness or (and) weakness. 5. Increased blood eosinophils, alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase and bilirubin may occur.

Keep in a light-proof and sealed container. The validity period is tentatively 18 months.

30mg

Harbin Medical University Pharmaceutical Co., Ltd.

• Founded in:

  1998-04-08

• Address:

  Bohai Road, Central Area, Haping Road, Harbin Development Zone

• Tax NO.:

  91230199702953105L

• Registered Funds:

  56.9258 million yuan

• Website:

  Log in to view

• Email:

  Log in to view